Recent Quotes (30 days)

You have no recent quotes
chg | %

Hamilton Thorne Ltd  

(Public, CVE:HTL)   Watch this stock  
Find more results for HTL
0.000 (0.00%)
Delayed:   3:59PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.05 - 0.51
Open     -
Vol / Avg. 0.00/25,953.00
Mkt cap 18.96M
P/E 15.32
Div/yield     -
EPS 0.02
Shares 59.60M
Beta 3.04
Inst. own     -
May 20, 2015
Q1 2015 Hamilton Thorne Ltd Earnings Release
May 20, 2015
Q1 2015 Hamilton Thorne Ltd Earnings Release
Apr 23, 2015
Q4 2014 Hamilton Thorne Ltd Earnings Release

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 17.80% 9.83%
Operating margin 20.51% 12.55%
EBITD margin - 13.46%
Return on average assets 61.02% 29.99%
Return on average equity - -
CDP Score - -


100 Cummings Ctr Ste 465e
BEVERLY, MA 01915-6143
United States - Map
+1-978-9212050 (Phone)
+1-978-9210250 (Fax)

Website links


Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company’s customers include Harvard, MIT, Yale, McGill, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, and Oxford and Cambridge. The Company’s Computer Assisted Sperm Analysis (CASA) image analysis systems are designed for the study of reproductive cells in the human fertility, animal sciences and reproductive toxicology fields. The Company sells its products through its direct sales force and through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments around the world.

Officers and directors

Meg D. Spencer Chairman of the Board
David Wolf President, Chief Executive Officer, Director
Michael W. Bruns CPA Chief Financial Officer, Vice President - Finance
Age: 55
Diarmaid H. Douglas-Hamilton Corporate Secretary, Chief Technology Officer and Senior Vice-President - Research & Development of the Corporation, Director
Thomas Kenny Vice President - Engineering
Dean Gendron Independent Director
Bruno C. Maruzzo Independent Director
Age: 60
Robert J. Potter Independent Director
David B. Sable M.D. Independent Director
Daniel K. Thorne Independent Director
Age: 52